Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

GT Biopharma, Inc. (GTBP) vs Phio Pharmaceuticals Corp. (PHIO)

GT Biopharma, Inc. and Phio Pharmaceuticals Corp. are both Biotechnology companies. GT Biopharma, Inc. and Phio Pharmaceuticals Corp. are of similar size ($12.4M and $12.3M). Phio Pharmaceuticals Corp. grew revenue faster over the last twelve months: 79.0% against −76.2%. Across the 13 metrics below, Phio Pharmaceuticals Corp. leads on 9 and GT Biopharma, Inc. on 4.

Valuation

Metric GTBP PHIO Biotechnology median
P/E n/m n/m 7.88
P/S 178.31 86.27 11.47
P/B 3.00 0.93 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.09 0.74
EV/Sales 96.13 (9.03) 10.73
Earnings yield (2,140.78%) (127.72%) (28.84%)
Free cash flow yield (133.29%) (104.03%) (23.03%)

Profitability

Metric GTBP PHIO Biotechnology median
Gross margin 41.67% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 102.03% (113.71%) (57.72%)
Return on assets (176.27%) (100.78%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GTBP PHIO Biotechnology median
Revenue growth (TTM) (76.19%) 78.95% 5.64%
EPS growth (last fiscal year) 3.75% 84.03% —
Revenue growth, 5-year CAGR 19.67% (21.62%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GTBP PHIO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.61 8.39 4.73
Net debt to EBITDA 0.56 2.28 0.96

Dividend

Metric GTBP PHIO Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric GTBP PHIO Biotechnology median
Market cap 12.32m 12.43m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack